You can buy or sell MorphoSys and other stocks, options, ETFs, and crypto commission-free!
MorphoSys AG engages in the development of antibodies for therapeutic, diagnostics, and research applications. It operates through the Proprietary Development and Partnered Discovery segments. Read More The Proprietary Development segment combines proprietary research and development of therapeutic compounds. The Partnered Discovery segment offers technologies to make human antibody-based therapeutics on behalf of partners in the pharmaceutical industry. The company was founded by Andreas Pluckthun and Simon E. Moroney in July 1992 and is headquartered in Planegg, Germany.
Planegg, Bayern (Bavaria)
52 Week High
52 Week Low
Expected Mar 11, After Hours